Managing Pharmacy Costs and Driving Value Creation Within Your Portfolio Companies (Webinar)

Each year, Private Equity firms and their Portfolio Companies leave hundreds of millions of dollars of potential pharmacy savings on the table by not having a proper pharmacy optimization plan in place. Beyond these unrealized savings, they are also likely exposing themselves to the high risks associated with specialty drugs cost claims.

With no end in sight to the increasing cost of pharmacy spending, companies are struggling to find solutions that contain costs and mitigate against future EBITDA impact to their company’s financial performance.

Join us for a learning session with Private Equity industry expert Doug Vandenberg and RxBenefits’ Chief Pharmacy Officer as we delve deeper into pharmacy benefits and how PE firms can help their Portfolio Companies identify immediate areas of savings and mitigate risk.

Speakers:

• Peter Lombardi, Executive Advisor, Private Equity, RxBenefits
• Mark Campbell, Pharm.D., Chief Pharmacy Officer, RxBenefits
• Doug Vandenberg, Managing Principal, Vieve